PDRX OTC
PD-Rx Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: -7.5%
YTD: +6.9%
1Y: +8.8%
3Y: -48.3%
5Y: +8.8%
$3.10
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
-175.5% ▼
Capital Expenditures
$78K
+81.7% ▲
5Y CAGR: -11.8%
Free Cash Flow
-$1M
-204.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$1K
-76.1% ▼
Net Change in Cash
-$1M
-205.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$384K | $2M | $3M | -$98K | -$753K |
| Depreciation & Amort. | $161K | $115K | $127K | $139K | $152K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$406K | -$2M | $8K | $2M | -$963K |
| Other Non-Cash Items | -$33K | -$695K | $66K | -$150K | $177K |
| Operating Cash Flow | -$587K | -$466K | $3M | $2M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$50K | -$108K | -$550K | -$427K | -$78K |
| Acquisitions (Net) | $0 | $22K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $750K | $0 | $48K | $0 | $0 |
| Investing Cash Flow | $700K | -$86K | -$503K | -$427K | -$78K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | -$165K | -$710 | -$1K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $934K | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $934K | $0 | -$165K | -$710 | -$1K |
| Net Change in Cash | $1M | -$552K | $3M | $1M | -$1M |
| Cash End of Period | $3M | $3M | $5M | $7M | $5M |
| Free Cash Flow | -$636K | -$574K | $3M | $1M | -$1M |